Imaging study of using positron emission tomography to compare the the effect of SSRI on serotonin transporter

Imaging study of using positron emission tomography to compare the the effect of SSRI on serotonin transporter - Comparative study of the effect of SSRI on serotonin transporter

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009741

Enrollment

Registered

2013-02-01

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adults

Interventions

PET, MRI, blood concentration, hepatic metabolizing enzyme PET, MRI, blood concentration, hepatic metabolizing enzyme PET, MRI, blood concentration, hepatic metabolizing enzyme PET, MRI, blood concent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who have the ability to provide informed consent and adhere to the protocol.

Exclusion criteria

Exclusion criteria: Exclusion criteria: - with past or current history of psychiatric illness - with past or current history of serious medical illness and/or brain organic diseases - subject who is contraindicated for the use of MRI - with past or current history ofsevere liver disease, kidney disease, heart disease, allergy, or severe drug allergy - taking drug which has interaction with SSRI - subject who are judged as not suitable for participation in this study

Design outcomes

Primary

Measure	Time frame
serotonin transporter binding potential	—

Secondary

Measure	Time frame
blood concentration, MRI, hepatic metabolizing enzyme	—

Countries

Japan

Contacts

Public ContactAmane Tateno

Nippon Medical School Department of Neuropsychiatry

amtateno@nms.ac.jp+81-3-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026